Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Thiamine as an adjunctive therapy in cardiac surgery: a randomized, double-blind, placebo-controlled, phase II trial.

Andersen LW, Holmberg MJ, Berg KM, Chase M, Cocchi MN, Sulmonte C, Balkema J, MacDonald M, Montissol S, Senthilnathan V, Liu D, Khabbaz K, Lerner A, Novack V, Liu X, Donnino MW.

Crit Care. 2016 Mar 14;20(1):92. doi: 10.1186/s13054-016-1245-1.

2.

Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study.

Donnino MW, Andersen LW, Chase M, Berg KM, Tidswell M, Giberson T, Wolfe R, Moskowitz A, Smithline H, Ngo L, Cocchi MN; Center for Resuscitation Science Research Group.

Crit Care Med. 2016 Feb;44(2):360-7. doi: 10.1097/CCM.0000000000001572.

PMID:
26771781
3.

Biochemical changes correlated with blood thiamine and its phosphate esters levels in patients with diabetes type 1 (DMT1).

Al-Daghri NM, Alharbi M, Wani K, Abd-Alrahman SH, Sheshah E, Alokail MS.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13483-8. eCollection 2015.

4.

Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes.

Porta M, Toppila I, Sandholm N, Hosseini SM, Forsblom C, Hietala K, Borio L, Harjutsalo V, Klein BE, Klein R, Paterson AD; DCCT/EDIC Research Group, Groop PH; FinnDiane Study Group.

Diabetes. 2016 Apr;65(4):1022-30. doi: 10.2337/db15-1247. Epub 2015 Dec 30.

PMID:
26718501
5.

Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives?

Serhiyenko VA, Serhiyenko AA.

World J Diabetes. 2015 Mar 15;6(2):245-58. doi: 10.4239/wjd.v6.i2.245. Review.

6.

Thiamin deficiency in people with obesity.

Kerns JC, Arundel C, Chawla LS.

Adv Nutr. 2015 Mar 13;6(2):147-53. doi: 10.3945/an.114.007526. Print 2015 Mar. Review.

7.

Evidence for altered thiamine metabolism in diabetes: Is there a potential to oppose gluco- and lipotoxicity by rational supplementation?

Pácal L, Kuricová K, Kaňková K.

World J Diabetes. 2014 Jun 15;5(3):288-95. doi: 10.4239/wjd.v5.i3.288. Review.

8.

The relationship between lactate and thiamine levels in patients with diabetic ketoacidosis.

Moskowitz A, Graver A, Giberson T, Berg K, Liu X, Uber A, Gautam S, Donnino MW.

J Crit Care. 2014 Feb;29(1):182.e5-8. doi: 10.1016/j.jcrc.2013.06.008. Epub 2013 Aug 28.

9.

Glucose-induced down regulation of thiamine transporters in the kidney proximal tubular epithelium produces thiamine insufficiency in diabetes.

Larkin JR, Zhang F, Godfrey L, Molostvov G, Zehnder D, Rabbani N, Thornalley PJ.

PLoS One. 2012;7(12):e53175. doi: 10.1371/journal.pone.0053175. Epub 2012 Dec 28.

10.

Benfotiamine counteracts smoking-induced vascular dysfunction in healthy smokers.

Stirban A, Nandrean S, Kirana S, Götting C, Veresiu IA, Tschoepe D.

Int J Vasc Med. 2012;2012:968761. doi: 10.1155/2012/968761. Epub 2012 Oct 3.

11.

Effects of combined dietary chromium(III) propionate complex and thiamine supplementation on insulin sensitivity, blood biochemical indices, and mineral levels in high-fructose-fed rats.

Król E, Krejpcio Z, Michalak S, Wójciak RW, Bogdański P.

Biol Trace Elem Res. 2012 Dec;150(1-3):350-9. doi: 10.1007/s12011-012-9515-5. Epub 2012 Oct 16.

12.

Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?

Farmer KL, Li C, Dobrowsky RT.

Pharmacol Rev. 2012 Oct;64(4):880-900. doi: 10.1124/pr.111.005314. Epub 2012 Aug 10. Review.

13.

Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy.

Alkhalaf A, Kleefstra N, Groenier KH, Bilo HJ, Gans RO, Heeringa P, Scheijen JL, Schalkwijk CG, Navis GJ, Bakker SJ.

PLoS One. 2012;7(7):e40427. doi: 10.1371/journal.pone.0040427. Epub 2012 Jul 6.

14.

The impact of thiamine treatment in the diabetes mellitus.

Luong KV, Nguyen LT.

J Clin Med Res. 2012 Jun;4(3):153-60. doi: 10.4021/jocmr890w. Epub 2012 May 15.

15.

The malnutrition of obesity: micronutrient deficiencies that promote diabetes.

Via M.

ISRN Endocrinol. 2012;2012:103472. doi: 10.5402/2012/103472. Epub 2012 Mar 15.

16.

Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia.

Satyanarayana A, Balakrishna N, Pitla S, Reddy PY, Mudili S, Lopamudra P, Suryanarayana P, Viswanath K, Ayyagari R, Reddy GB.

PLoS One. 2011;6(11):e26747. doi: 10.1371/journal.pone.0026747. Epub 2011 Nov 1.

17.

Construction of a thiamin sensor from the periplasmic thiamin binding protein.

Hanes JW, Chatterjee D, Soriano EV, Ealick SE, Begley TP.

Chem Commun (Camb). 2011 Feb 28;47(8):2273-5. doi: 10.1039/c0cc04228e. Epub 2010 Dec 2.

18.

Oxidative stress and diabetic complications.

Giacco F, Brownlee M.

Circ Res. 2010 Oct 29;107(9):1058-70. doi: 10.1161/CIRCRESAHA.110.223545. Review.

19.

A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy.

Alkhalaf A, Klooster A, van Oeveren W, Achenbach U, Kleefstra N, Slingerland RJ, Mijnhout GS, Bilo HJ, Gans RO, Navis GJ, Bakker SJ.

Diabetes Care. 2010 Jul;33(7):1598-601. doi: 10.2337/dc09-2241. Epub 2010 Apr 22.

20.

Pancreatic beta cells and islets take up thiamin by a regulated carrier-mediated process: studies using mice and human pancreatic preparations.

Mee L, Nabokina SM, Sekar VT, Subramanian VS, Maedler K, Said HM.

Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G197-206. doi: 10.1152/ajpgi.00092.2009. Epub 2009 May 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk